Present and future therapies of hepatitis B: From discovery to cure

Author:

Liang T. Jake1,Block Timothy M.2,McMahon Brian J.3,Ghany Marc G.1,Urban Stephan4,Guo Ju-Tao2,Locarnini Stephen5,Zoulim Fabien6,Chang Kyong-Mi7,Lok Anna S.8

Affiliation:

1. Liver Diseases Branch; National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health; Bethesda MD

2. Baruch S. Blumberg Institute; Doylestown PA

3. National Center for Emerging and Zoonotic Infectious Diseases; Centers for Disease Control and Prevention; Anchorage AK

4. Department of Infectious Diseases; Molecular Virology and German Center for Infection Diseases, University Hospital Heidelberg; Heidelberg Germany

5. Hepatology Department; Lyon University and Cancer Research Center of Lyon, INSERM U1052; Lyon France

6. Victorian Infectious Diseases Reference Laboratory; Doherty Institute; Melbourne VIC Australia

7. Department of Medicine; Philadelphia Veterans Affairs Medical Center and the University of Pennsylvania Perelman School of Medicine; Philadelphia PA

8. Division of Gastroenterology and Hepatology; University of Michigan; Ann Arbor MI

Publisher

Wiley

Subject

Hepatology

Cited by 257 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3